Injectable face market in usa
Dublin, July 11, 2024 (GLOBE NEWSWIRE) — U.S “US Injectable Market Size Report, Share and Analysis Trends by Product (Botulinum Toxin Type A, HA), Application (Facial Line Correction, Lip Augmentation), End Use, Region and Segment Forecasts, 2024-2030” reference has been added to ResearchAndMarkets.com special offer.
The US facial injectables market is expected to reach USD 8.02 billion by 2030, exhibiting a CAGR of 11.1% from 2024 to 2030
Increasing acceptance of cosmetic procedures and growing geriatric population are some of the major factors driving the growth of the market.
The growing geriatric population of the US is increasing the demand for the development of minimally invasive surgical procedures. Facial injectables offer an alternative to many cosmetic surgeries. In addition, these procedures offer many advantages, such as less pain, less trauma, less blood loss, and faster recovery. Additionally, increasing focus of market players on developing demand-specific solutions with less risk of allergy is contributing significantly to market growth.
Growing awareness about cosmetic procedures due to increasing focus on facial appearance is further driving the market growth. Moreover, the availability of injectable face to meet different requirements of the patients has increased their demand in different age groups according to their needs. For example, according to the American Society of Plastic Surgeons’ 2022 Plastic Surgery Statistical Report, the number of neuromodulator injection procedures in the 30 to 39 and 40 to 54 age group in 2022 has increased by 70% and 74% from 2019 at the same time. .
Similarly, the number of HA filler procedures in the 30 to 39 and 40 to 54 age group in 2022 has increased by 69% and 70% from 2019 at the same time. This growing demand for injectable facial products across different age groups is expected to drive the growth of the market during the forecast period.
Key Points of Reference for the US Injectable Market
-
Botulinum toxin type A dominated the product segment with a share of more than 55% in 2023 due to its wide treatment such as wrinkles, lymph node lines, lateral canthus and others.
-
The HA segment is expected to witness the fastest growth during the forecast period owing to the increasing focus of market players on the development of hyaluronic fillers. Growing demand for minimally invasive procedures and increase in cosmetic procedures are driving the market growth.
-
In May 2023, Evolus, Inc. announced that the company had entered into an agreement with Symatese to be the distributor of five under-development derma fillers. This step significantly helped the company to expand its product portfolio and take a step towards becoming a multi-product beauty company.
Selected companies
-
AbbVie, Inc.
-
REVANCE AESTHETICS
-
Merz North America, Inc.
-
Galderma Laboratories, LP
-
Suneva Medical Inc.
-
Cytophil, Inc
-
Prollenium Medical Technologies.
Basic features:
|
Attribute reference |
Details |
|
Number of Pages |
70 |
|
Prognostic period |
2023 – 2030 |
|
Estimated market value (USD) in 2023 |
$3.88 billion |
|
Projected market value (USD) by 2030 |
$8.02 billion |
|
Compound Annual Growth Rate |
11.1% |
|
Covered Areas |
United States |
Key topics covered:
Chapter 1. Methodology and Scope
Chapter 2. Summary
2.1. Market prospects
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. US Facial Injectables Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market prospects
3.1.2. Related/Ancillary Market Prospects
3.2. Market Dynamics
3.2.1. Market guide analysis
3.2.1.1. Increase in Geriatric Population
3.2.1.2. Increasing awareness of aesthetic processes
3.2.1.3. Increasing the availability of innovative products
3.2.1.4. Increase in the number of cosmetic procedures performed
3.2.2. Market constraint analysis
3.2.2.1. Threat of side effects
3.3. US Injectables Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces
3.3.2. PESTEL analysis
Chapter 4. U.S. Facial Injectables Market: Product Estimates & Trend Analysis
4.1. Product market share, 2023 & 2030
4.2. Section control panel
4.3. US Facial Injectables Market by Product Outlook
4.4. Market Size and Forecasts and Trend Analysis, 2018 to 2030
4.4.1. Collagen microspheres & PMMA
4.4.2. Botulism toxin Type a
4.4.3. HA
4.4.4. CaHA
4.4.5. PLLA
Chapter 5. U.S. Facial Injectables Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Section control panel
5.3. US Facial Injectables Market by Application Outlook
5.4. Market Size and Forecasts and Trend Analysis, 2018 to 2030
5.4.1. Correction of facial lines
5.4.2. Lip augmentation
5.4.3. Face lifting
5.4.4. Acne scar treatment
5.4.5. Lipoatrophy Treatment
Chapter 6. United States Facial Injectable Market: End-Use Estimates and Trend Analysis
6.1. End-use market share, 2023 & 2030
6.2. Section control panel
6.3. US Facial Injectable Market by End Use Outlook
6.4. Market Size and Forecasts and Trend Analysis, 2018 to 2030
6.4.1. MedSpa
6.4.2. Dermatology Clinics
6.4.3. Hospitals
Chapter 7. U.S. Facial Injectables Market: Region Estimates & Trend Analysis
7.1. Regional Market Share, 2023 & 2030
7.2. US Facial Injectables Market by Region Outlook
7.3. Market Size and Forecasts and Trend Analysis, 2018 to 2030
7.3.1. west
7.3.2. Midwest)
7.3.3. Northeastern
7.3.4. Southwest
7.3.5. Southeast
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Seller landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key Company Heatmap Analysis, 2023
8.4. Company Profiles
8.4.1. Company overview
8.4.2. Financial performance
8.4.3. Comparative evaluation of products
8.4.4. Strategic Initiatives
For more information on this report visit https://www.researchandmarkets.com/r/648e6x
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.
Attached
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
